"A recent study presented by Srirangam et al reported that another protease inhibitor (PI), ritonavir, partially inhibit the functions of Hsp90 (KD =7.8 μM)." #HSP90 https://t.co/C4lo0CIGDg
"A recent study presented by Srirangam et al reported that another protease inhibitor (PI), ritonavir, partially inhibit the functions of Hsp90 (KD =7.8 μM)." #HSP90 https://t.co/C4lo0CIGDg
https://t.co/Udj3NRRvhC "A recent study presented by Srirangam et al reported that another protease inhibitor (PI), ritonavir, partially inhibit the functions of Hsp90 (KD =7.8 μM)." #HSP90
https://t.co/Udj3NRRvhC "Indinavir, saquinavir, and ritonavir have close binding affinity to NFV (ΔG =−9.0, −8.6, and −8.5 kcal/mol, respectively)."
https://t.co/Udj3NRRvhC "Results showed that NFV has better binding affinity (ΔG =−9.2 kcal/mol) when compared with other PIs: this is in a reasonable accordance with the experimental data (IC50 3.1 μM)."
https://t.co/Udj3NRRvhC "Based on experimental data, the anticancer activity of nelfinavir (NFV), a US Food and Drug Administration (FDA)-approved HIV-1 protease inhibitor (PI), was reported."
Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses #MECFS #LongCovid #HSP90 https://t.co/Udj3NRRvhC
Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced… https://t.co/mBYDSXfiu0 #breastcancer
HIV PR inhibitors as potential anticancer agents https://t.co/nI3UrptKS1